Abstract:Fibrinogen molecules are comprised of two sets of disulfide-bridged Aalpha-, Bbeta-, and gamma-chains. Each molecule contains two outer D domains connected to a central E domain by a coiled-coil segment. Fibrin is formed after thrombin cleavage of fibrinopeptide A (FPA) from fibrinogen Aalpha-chains, thus initiating fibrin polymerization. Double-stranded fibrils form through end-to-middle domain (D:E) associations, and concomitant lateral fibril associations and branching create a clot network. Fibrin assembly facilitates intermolecular antiparallel C-terminal alignment of gamma-chain pairs, which are then covalently 'cross-linked' by factor XIII ('plasma protransglutaminase') or XIIIa to form 'gamma-dimers'. In addition to its primary role of providing scaffolding for the intravascular thrombus and also accounting for important clot viscoelastic properties, fibrin(ogen) participates in other biologic functions involving unique binding sites, some of which become exposed as a consequence of fibrin formation. This review provides details about fibrinogen and fibrin structure, and correlates this information with biological functions that include: (i) suppression of plasma factor XIII-mediated cross-linking activity in blood by binding the factor XIII A2B2 complex. (ii) Non-substrate thrombin binding to fibrin, termed antithrombin I (AT-I), which down-regulates thrombin generation in clotting blood. (iii) Tissue-type plasminogen activator (tPA)-stimulated plasminogen activation by fibrin that results from formation of a ternary tPA-plasminogen-fibrin complex. Binding of inhibitors such as alpha2-antiplasmin, plasminogen activator inhibitor-2, lipoprotein(a), or histidine-rich glycoprotein, impairs plasminogen activation. (iv) Enhanced interactions with the extracellular matrix by binding of fibronectin to fibrin(ogen). (v) Molecular and cellular interactions of fibrin beta15-42. This sequence binds to heparin and mediates platelet and endothelial cell spreading, fibroblast proliferation, and capillary tube formation. Interactions between beta15-42 and vascular endothelial (VE)-cadherin, an endothelial cell receptor, also promote capillary tube formation and angiogenesis. These activities are enhanced by binding of growth factors like fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF), and cytokines like interleukin (IL)-1. (vi) Fibrinogen binding to the platelet alpha(IIb)beta3 receptor, which is important for incorporating platelets into a developing thrombus. (vii) Leukocyte binding to fibrin(ogen) via integrin alpha(M)beta2 (Mac-1), which is a high affinity receptor on stimulated monocytes and neutrophils.

Structure-Function Relationships of Human Coagulation Proteins

Coagulation System/Physiology

In-depth structure-function profiling of the complex formation between clotting factor VIII and heme

Comprehensive Analysis of the Role of Fibrinogen and Thrombin in Clot Formation and Structure for Plasma and Purified Fibrinogen

Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation

Tissue factor (:Factor VIIa) in the heart and vasculature: More than an envelope

Fibrinogen and fibrin structure and functions

Tissue factor at the crossroad of coagulation and cell signaling

Fibrinogen and fibrin: An illustrated review

Blood coagulation factor IX: structural insights impacting hemophilia B therapy

Vitamin K-dependent carboxylation of coagulation factors: insights from a cell-based functional study

Complement-coagulation connections

Structure And Evolution Of The Human Genes Encoding Protein-C And Coagulation Factor-Ix

Microrheology and structural quantification of hypercoagulable clots

Hemostasis and endothelial functionality: the double face of coagulation factors

Complement-Coagulation Cross-talk: Factor H-mediated regulation of the Complement Classical Pathway activation by fibrin clots

Endothelial cells and coagulation

Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System.

Modeling the distribution of enzymes on lipid vesicles: A novel framework for surface-mediated reactions in coagulation

Physical forces regulating hemostasis and thrombosis: Vessels, cells, and molecules in illustrated review

Mechanisms Regulating Acquisition of Platelet-Derived Factor V/Va by Megakaryocytes